M.D., PhD.,CPI®(ACRP), chief psychiatrist of Shanghai Mental Health Center (SMHC) and a doctoral mentor of Shanghai Jiao Tong University School of Medicine. Currently she is the executive director of National Drug Clinical Trial Institute, SMHC. Her main research interests include clinical trials of new drugs in psychiatry and psychopharmacology. As the leading-PI, she has conducted more than 50 clinical trials related to the different kinds of psychotropics including drugs for schizophrenia, depression, bipolar disorder, insomnia and etc.
She has published more than 220 papers. Since 2008 she has been being the PI of the “National Major Project for IND”--“New Psychotic Drugs Evaluation and Research Project” (in China). Dr. Li is dedicated to and enthused over the development of new drugs in Psychiatry. At present, she is the leading-PI for five innovative drugs.